Joanne Gibbons is a senior consultant and Emily Welsch is a consultant at Halloran Consulting Group, a specialty consulting firm to life science companies focusing on clinical, regulatory and quality.
Consumers and life science startup companies alike are reacting strongly to the recent decision by the FDA to restrict the genetic testing company, 23andMe, from marketing its genetic testing service. In... Read more »
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.